BODALCHEM

Current scenario - Structural shifts in China are supporting better price realization for dye intermediates and dyestuff. - Benzene downstream plant capacity utilization improved significantly, expected to contribute to net profit from current quarter. - TCCA business facing challenges with Chinese equipment imports, planning to procure locally to expand capacity. Management Guidance & Outlook - Targeting over INR 3,000 crores revenue for FY27 with sustained EBITDA margins around 12% to 14%. - FY28 expected to witness volume growth driven by higher utilization in benzene derivatives, TCCA, and dyestuff. - Focused on reducing long-term debt through internal accruals and keeping capital allocation in check (organic/inorganic capex in range of INR 100-200 crores). Capex & Growth Drivers - No immediate plans to expand H acid or vinyl sulfone capacities as existing plants are operating at optimum levels; brownfield expansions possible within 12 months if structural shifts sustain. - Debt reduction and optimization of working capital remain key priorities.

- Bodal Chemicals Limited has informed the exchanges regarding the availability of the audio recording for the analyst conference call held on 03-11-2026. - The call was regarding the financial performance for the quarter and half year ended 30th September 2026. - The recording can be accessed via the link provided in the company's website.

Q2 FY27 Consolidated Revenue ₹8,634Cr vs ₹4,805Cr (▲79.7% YoY) EBITDA ₹1,276Cr vs ₹429Cr (▲197.4% YoY) PAT ₹814Cr vs ₹60Cr (▲1,256.7% YoY) EBITDA Margin 14.8% vs 8.9% (▲590bps)

- Board of Directors approved standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2026. - Statutory Auditors M/s. B N P S and Associates LLP issued Limited Review Reports. - Meeting was held on November 03, 2026, from 12:36 PM to 1:55 PM.

Concall Schedule Concall Date: 3rd November 2026 Concall Time: 04:30 PM IST